Skip to main content

Advertisement

SpringerLink
Log in

Methyl-β-cyclodextrin treatment combined to incubation with interleukin-4 reproduces major features of atopic dermatitis in a 3D-culture model

  • Concise Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Atopic dermatitis (AD) skin is characterized by over-expression of interleukin (IL)-4, IL-13 and IL-25. When methyl-β-cyclodextrin (MβCD) treatment preceded exposure to these interleukins, combination of both treatments was found to mimic hallmarks of AD in vitro, such as barrier weakening, histological alterations and typical signaling responses in a reconstructed human epidermis (RHE). However, the respective role of each IL and whether any of them is critical when combined with MβCD treatment was unknown. Therefore, this work aimed to distinguish RHE responses after exposure to MβCD and each one of the three IL reported to mimic typical features of AD. IL-4 incubation preceded by MβCD was found responsible for altered histology, as well as for barrier alterations, evidenced by electrical resistance and dye permeation measurements. This combination further decreased loricrin (LOR) immunoreactivity, whereas mainly IL-25, combined to MβCD treatment, was able to downregulate filaggrin (FLG) mRNA level. Carbonic anhydrase II (CA2) and hyaluronan synthase 3 (HAS3), two other markers up-regulated in AD, were also induced when MβCD treatment was followed by IL-4, whilst the expression of neural epidermal growth factor-like 2 (NELL2) was up-regulated by paired IL-4 and IL-13. In conclusion, multiple features of AD were found in this in vitro model mainly when treatment of RHE by IL-4 was conducted after preliminary MβCD incubation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Akaiwa M, Yu B, Umeshita-Suyama R, Terada N, Suto H, Koga T, Arima K, Matsushita S, Saito H, Ogawa H, Furue M, Hamasaki N, Ohshima K, Izuhara K (2001) Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine 13(2):75–84

    Article  CAS  PubMed  Google Scholar 

  2. Bogiatzi SI, Fernandez I, Bichet JC, Marloie-Provost MA, Volpe E, Sastre X, Soumelis V (2007) Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 178(6):3373–3377

    Article  CAS  PubMed  Google Scholar 

  3. Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, El Ghalbzouri A, Bouwstra JA (2014) TNF-alpha and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol 134(7):1941–1950

    Article  CAS  PubMed  Google Scholar 

  4. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Novak N, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127(3):773–786 e771–e777

  5. De Vuyst E, Charlier C, Giltaire S, De Glas V, de Rouvroit CL, Poumay Y (2014) Reconstruction of normal and pathological human epidermis on polycarbonate filter. Methods Mol Biol 1195:191–201

    Article  PubMed  Google Scholar 

  6. De Vuyst E, Giltaire S, Lambert de Rouvroit C, Chretien A, Salmon M, Poumay Y (2015) The activation of cultured keratinocytes by cholesterol depletion during reconstruction of a human epidermis is reminiscent of monolayer cultures. Arch Dermatol Res 307(4):309–318

    Article  PubMed  Google Scholar 

  7. De Vuyst E, Giltaire S, Lambert de Rouvroit C, Malaisse J, Mound A, Bourtembourg M, Nikkels AF, Chretien A, Salmon M, Poumay Y (2016) MβCD concurs with IL-4, IL-13 and IL-25 to induce alterations reminiscent of atopic dermatitis in reconstructed human epidermis. Exp Dermatol. doi:10.1111/exd.13113

    PubMed  Google Scholar 

  8. Frankart A, Malaisse J, De Vuyst E, Minner F, de Rouvroit CL, Poumay Y (2012) Epidermal morphogenesis during progressive in vitro 3D reconstruction at the air-liquid interface. Exp Dermatol 21(11):871–875

    Article  PubMed  Google Scholar 

  9. Giltaire S, Lambert S, Poumay Y (2011) HB-EGF synthesis and release induced by cholesterol depletion of human epidermal keratinocytes is controlled by extracellular ATP and involves both p38 and ERK1/2 signaling pathways. J Cell Physiol 226(6):1651–1659

    Article  CAS  PubMed  Google Scholar 

  10. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94(2):870–876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Honzke S, Wallmeyer L, Ostrowski A, Radbruch M, Mundhenk L, Schafer-Korting M, Hedtrich S (2016) Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and ss-defensins in Filaggrin-deficient skin equivalents. J Invest Dermatol 136(3):631–639

    Article  PubMed  Google Scholar 

  12. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124(3 Suppl 2):R7–R12

    Article  CAS  PubMed  Google Scholar 

  13. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M (2011) IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131(1):150–157

    Article  CAS  PubMed  Google Scholar 

  14. Jans R, Atanasova G, Jadot M, Poumay Y (2004) Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38. J Invest Dermatol 123(3):564–573

    Article  CAS  PubMed  Google Scholar 

  15. Kamsteeg M, Bergers M, de Boer R, Zeeuwen PLJM, Hato SV, Schalkwijk J, Tjabringa GS (2011) Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent. Am J Pathol 178(5):2091–2099

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kamsteeg M, Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Zeeuwen-Franssen ME, van Erp PE, Schalkwijk J (2007) Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic dermatitis: regulation by Th2 cytokines. J Invest Dermatol 127(7):1786–1789

    Article  CAS  PubMed  Google Scholar 

  17. Kim BE, Bin L, Ye YM, Ramamoorthy P, Leung DY (2013) IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol 133(12):2678–2685

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kim BE, Leung DY, Boguniewicz M, Howell MD (2008) Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 126(3):332–337

    Article  CAS  PubMed  Google Scholar 

  19. Leung DYM, Bieber T (2003) Atopic dermatitis. The Lancet 361(9352):151–160

    Article  Google Scholar 

  20. Malaisse J, Bourguignon V, De Vuyst E, Lambert de Rouvroit C, Nikkels AF, Flamion B, Poumay Y (2014) Hyaluronan metabolism in human keratinocytes and atopic dermatitis skin is driven by a balance of hyaluronan synthases 1 and 3. J Invest Dermatol 134(8):2174–2182

    Article  CAS  PubMed  Google Scholar 

  21. Mathay C, Pierre M, Pittelkow MR, Depiereux E, Nikkels AF, Colige A, Poumay Y (2011) Transcriptional profiling after lipid raft disruption in keratinocytes identifies critical mediators of atopic dermatitis pathways. J Invest Dermatol 131(1):46–58

    Article  CAS  PubMed  Google Scholar 

  22. Minner F, Poumay Y (2009) Candidate housekeeping genes require evaluation before their selection for studies of human epidermal keratinocytes. J Invest Dermatol 129(3):770–773

    Article  CAS  PubMed  Google Scholar 

  23. Noda S, Suarez-Farinas M, Ungar B, Kim SJ, de Guzman Strong C, Xu H, Peng X, Estrada YD, Nakajima S, Honda T, Shin JU, Lee H, Krueger JG, Lee KH, Kabashima K, Guttman-Yassky E (2015) The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol 136(5):1254–1264

    Article  CAS  PubMed  Google Scholar 

  24. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112(6):1195–1202

    Article  CAS  PubMed  Google Scholar 

  25. Ohtani T, Memezawa A, Okuyama R, Sayo T, Sugiyama Y, Inoue S, Aiba S (2009) Increased hyaluronan production and decreased E-cadherin expression by cytokine-stimulated keratinocytes lead to spongiosis formation. J Invest Dermatol 129(6):1412–1420

    Article  CAS  PubMed  Google Scholar 

  26. Pellerin L, Henry J, Hsu CY, Balica S, Jean-Decoster C, Mechin MC, Hansmann B, Rodriguez E, Weindinger S, Schmitt AM, Serre G, Paul C, Simon M (2013) Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol 131(4):1094–1102

    Article  CAS  PubMed  Google Scholar 

  27. Poumay Y, Dupont F, Marcoux S, Leclercq-Smekens M, Herin M, Coquette A (2004) A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res 296(5):203–211

    Article  CAS  PubMed  Google Scholar 

  28. Rouaud-Tinguely P, Boudier D, Marchand L, Barruche V, Bordes S, Coppin H, Roth MP, Closs B (2015) From the morphological to the transcriptomic characterization of a compromised three-dimensional in vitro model mimicking atopic dermatitis. Br J Dermatol 173(4):1006–1014

    Article  CAS  PubMed  Google Scholar 

  29. Saatian B, Rezaee F, Desando S, Emo J, Chapman T, Knowlden S, Georas SN (2013) Interleukin-4 and interleukin-13 cause barrier dysfunction in human airway epithelial cells. Tissue Barriers 1(2):e24333

    Article  PubMed  PubMed Central  Google Scholar 

  30. Seltmann J, Roesner LM, von Hesler FW, Wittmann M, Werfel T (2015) IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. J Allergy Clin Immunol 135(6):1659–1661 e1654

  31. Tazawa T, Sugiura H, Sugiura Y, Uehara M (2004) Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res 295(11):459–464

    Article  CAS  PubMed  Google Scholar 

  32. Thyssen JP, Kezic S (2014) Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 134(4):792–799

    Article  CAS  PubMed  Google Scholar 

  33. Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S, Hippe A, Corrigan CJ, Dong C, Homey B, Yao Z, Ying S, Huston DP, Liu YJ (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 204(8):1837–1847

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Wongpiyabovorn J, Suto H, Ushio H, Izuhara K, Mitsuishi K, Ikeda S, Nakao A, Okumura K, Ogawa H (2003) Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. J Dermatol Sci 33(1):31–40

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully thank B. Balau, V. De Glas and D. Van Vlaender for providing technical help. Special thanks are addressed to Dr. B. Bienfait (Clinique St. Luc, Namur-Bouge, Belgium) for providing skin samples.

Author information

Authors and Affiliations

  1. Research Unit for Molecular Physiology (URPhyM)-NARILIS, University of Namur, 61, rue de Bruxelles, B-5000, Namur, Belgium

    Tatiana do Nascimento Pedrosa, Evelyne De Vuyst, Abdallah Mound, Catherine Lambert de Rouvroit & Yves Poumay

  2. Skin Biology Laboratory, Clinical Chemistry and Toxicology Department, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

    Tatiana do Nascimento Pedrosa & Silvya Stuchi Maria-Engler

Authors
  1. Tatiana do Nascimento Pedrosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evelyne De Vuyst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdallah Mound
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine Lambert de Rouvroit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Silvya Stuchi Maria-Engler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yves Poumay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yves Poumay.

Ethics declarations

The authors state no conflict of interest. This study was conducted according to the Declaration of Helsinki Principles and approved by the Ethics Committees. Financial support was provided by FRFC 2.4.522.10F Grant to YP and FAPESP (Grant # 2015/23938-0) to TDNP.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 261 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

do Nascimento Pedrosa, T., De Vuyst, E., Mound, A. et al. Methyl-β-cyclodextrin treatment combined to incubation with interleukin-4 reproduces major features of atopic dermatitis in a 3D-culture model. Arch Dermatol Res 309, 63–69 (2017). https://doi.org/10.1007/s00403-016-1699-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-016-1699-7

Keywords

Search

Navigation